Development services

Outstanding biopharmaceutical services for all stages of development

Outstanding biopharmaceutical services for all stages of development

Coriolis is the expert partner of choice for biopharmaceutical development! We support our clients from early-stage research and preclinical phase to and beyond market approval by providing the right services for your needs including formulation development, lyophilization process development, forced degradation, stability studies, and product characterization. 

Our highly skilled project teams apply cutting-edge technologies tailored to your development phase. With our collaborative approach, we identify the most suitable study design to provide the best chances of success and to ensure your return on investment. 

Reach your development goals faster through science-driven and flexible solutions that align with your global strategy.

Early-stage development services for preclinical phases

Get on the right track early, with our tailored services for early R&D stages. Our experienced scientists perform developability and manufacturability assessments to assist in lead candidate selection, conduct preformulation studies to assess critical degradation pathways, develop simple yet robust and flexible formulations for your early-stage product and supply preclinical batches for toxicological studies. During project planning, we account for special project challenges such as limited supply of material, relevant deadlines, need for high-throughput analytical techniques, flexibility towards scope changes, need for readily available methods and procedures.

Clinical and late-stage development services

A robust drug product that is fit for clinical and commercial application: that is the goal of our clinical development and late-stage services. We develop liquid and lyophilized formulations and take application devices and container closure integrity of the primary packaging into account. Our expert scientists perform long-term as well as in-use stability studies and perform troubleshooting activities including the characterization and identification of (sub)visible particles. Modern cGMP facilities enable us the development, qualification, and validation of analytical methods on fully qualified equipment and a subsequent lot release testing with full QA involvement. 

Our development services

Let's talk!

Speak to our experts and learn how you can benefit from our science-drive development services.

Get in contact
Pure client orientation

Pure client orientation

As a privately held company, we are independent and accountable to nobody except you, our client. Therefore, we can provide our services with solely data-driven recommendations. With our collaborative approach and transparent communication strategy, you will always stay on top of the project. You will also benefit from the scientific excellence of our distinguished panel of scientific advisors. They are actively involved in the project strategy and discussions to provide their independent advice.

Read more
Full flexibility and transparency

Full flexibility and transparency

In our know-how-based collaboration, we disclose to you all required information from work plans and methods to raw data and final results. We also support the transfer of methods, formulations, and processes to your CMO for further development and commercialization. With a free license (under any applied Coriolis background IP) and exclusive use of your results (under the foreground IP), you maintain your flexibility. Coriolis demands no royalties or milestone payments.

Read more
Development projects for molecules of biosafety level S1 and S2

Development projects for molecules of biosafety level S1 and S2

Innovative drugs such as gene- and cell therapy products frequently utilize genetically modified organism or biological substances that fall under biosafety level S1 or S2. If you are working with a lentiviral vector or rely on cell cultures for your infectivity assay, we got you covered. In our facilities, we develop and analyze liquid and lyophilized drug products up to biosafety level S2. With dedicated biosafety officers, we take care of the biological safety assessment and regulatory paperwork to get project work stated as quickly as possible.

Read more
Analytical services under R&D and GMP

Analytical services under R&D and GMP

Besides our development services, we offer a number of analytical services for biopharmaceutical drugs and vaccines.

Our scientists are highly skilled in developing dedicated and robust analytical methods for your specific needs. We also maintain numerous in-house methods that can readily be applied to common sample types.

Get to know our analytical portfolio.

Read more

Contact us

Contact us

Please contact Dr. Stefan Heindl for enquiries related to our development services

Dr. Stefan Heindl